[1]
V. V. Chuhunov, V. I. Darii, D. M. Safonov, and A. D. Horodokin, “Pharmacogenic and neurologic components of residual condition in schizophrenia”, Zaporozhye Medical Journal, vol. 24, no. 6, pp. 710–713, Dec. 2022.